美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

PTP 概念

1,549.91

+3.990.26%

涨家数：21

跌家数：13

平家数：2

市盈率：- -

高：1,552.58

开：1,546.60

低：1,541.39

收：1,545.92

成交量：3,138.70万

成交额：7.48亿

市值：3,008.81亿

流通市值：1,923.85亿

数据加载中...

总览新闻资讯

礼来新一代“药王”替尔泊肽首次纳入国家医保，国内GLP-1竞争格局或生变

红星资本局

超20亿美元！辉瑞引进复星医药口服GLP-1药物

佰傲谷BioValley

多尔切斯特矿业L.P.宣布威廉·凯西·麦克马宁从经理委员会退休；罗伯特·C·沃恩被任命为临时主席，阿尔伯特·G·南斯三世加入董事会

辉瑞(PFE)盘前升近1% 与药友制药签订GLP-1R独家许可

替尔泊肽进医保，中国GLP-1的竞争彻底变天！

安徽省安庆市市场监督管理局公示2025年旅游产品质量联动抽查结果

中国质量新闻网

“五虎争霸赛”圆满收官｜JST、SUN、NFT 夺魁，SUN.io 接棒生态新动能

石药集团(01093)：GLP-1/GIP受体双偏向性激动多肽注射液在美国获临床试验批准

AETDEW 携手 AB 慈善基金会 X AB DAO 共解发展中国家能源难题

综述 2-受资本市场提振，加拿大道明银行、墨尔本银行和加拿大帝国商业银行利润超预期

司美格鲁肽等GLP-1药物写入WHO全球指南用于肥胖症治疗

中国生物制药(01177)：TQF3250“口服偏向型GLP-1受体激动剂”临床试验申请获NMPA、FDA批准

Plains All American Pipeline - 公司于12月1日终止Epic信贷协议并偿还未偿还金额 - SEC文件

汉堡王准备迎接GLP-1的变化

不止于交易：孙悟空如何用“真金白银”为SUN铸造价值闭环

AB 慈善基金会再次追加 500 万，三次捐款共 1500 万港币，与中国和平统一促进会香港总会践行“狮子山下精神”

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4590/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4590","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4590\",,,,,undefined,":{"symbol":"BK4590","market":"US","secType":"PLATE","nameCN":"PTP 概念","latestPrice":1549.912,"timestamp":1766005199999,"preClose":1545.9171,"halted":0,"volume":31386995,"delay":0,"changeRate":0.002584,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":3.994873,"latestTime":"12-17 16:00:00 EST","open":1546.5961,"high":1552.5833,"low":1541.3918,"amount":747857920.824706,"amplitude":0.007239,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1766019600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.916234,"peRate":14.897769,"turnoverRate":0.004244,"increases":21,"decrements":13,"flats":2,"marketCap":300881225792,"floatMarketCap":192385339426},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4590\",,,,,undefined,":{"symbol":"BK4590","high":1552.5833,"amplitude":0.007239,"preClose":1545.9171,"low":1541.3918,"pbRate":"2.916234","latestPrice":1549.912,"volume":31386995,"delay":0,"open":1546.5961,"prevYearClose":1541.1399,"prevWeekClose":1572.2839,"prevMonthClose":1582.8588,"prevQuarterClose":1529.3259,"fiveDayClose":1574.7545,"twentyDayClose":1548.4397,"sixtyDayClose":1537.5734,"secType":"PLATE","market":"US","turnoverRate":0.004244,"peRate":14.897769,"marketCap":300881225792,"floatMarketCap":192385339426,"timestamp":1766005199999,"nameCN":"PTP 概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4590\",,,,undefined,":{"bkCode":"BK4590","up":21,"down":13,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4590\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2590585172","title":"礼来新一代“药王”替尔泊肽首次纳入国家医保，国内GLP-1竞争格局或生变","url":"https://stock-news.laohu8.com/highlight/detail?id=2590585172","media":"红星资本局","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590585172?lang=zh_cn&edition=fundamental","pubTime":"2025-12-10 18:17","pubTimestamp":1765361836,"startTime":"0","endTime":"0","summary":"红星资本局12月10日消息，近日，国家医保局发布2025年《国家基本医疗保险、生育保险和工伤保险药品目录》，礼来（LLY.N）GIP/GLP-1RA双靶点降糖药，替尔泊肽注射液（商品名：穆峰达）获纳入，医保覆盖范围适用于成人2型糖尿病患者的血糖控制。近年来，新型降糖药物GLP-1RA（胰高血糖素样肽-1受体激动剂）受到广泛关注，国内赛道竞争也日益激烈。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512103587788820.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BJJMRY28.SGD","LU2106854487.HKD","LU1064131342.USD","LU0320765059.SGD","LU0079474960.USD","LU1712237335.SGD","BK4007","BK4588","LU1093756325.SGD","LU0882574139.USD","LU2456880835.USD","LU0471298694.HKD","LU0708995401.HKD","LU1057294990.SGD","LU1548497426.USD","SG9999018865.SGD","IE0009355771.USD","LU2023250504.SGD","LU2471134879.HKD","SGXZ51526630.SGD","LU2471134952.CNY","LU2265009873.SGD","LU0256863902.USD","LU2089984988.USD","LU2264538146.SGD","LU1061106388.HKD","LU2063271972.USD","LU2468319806.SGD","IE00BN29S564.USD","LU0823416689.USD","LU1988902786.USD","IE00BK4W5M84.HKD","LU1023059063.AUD","LU2168564149.EUR","SG9999014898.SGD","LU2746668461.USD","IE00B1BXHZ80.USD","LU1232071149.USD","LU0289739699.SGD","LU2361044865.SGD","LU2087625088.SGD","LU2237443382.USD","LU2552382215.SGD","LU2108987350.USD","LU1366192091.USD","LU2361044949.HKD","SG9999014914.USD","LU0096364046.USD","SG9999015945.SGD","LU2237443465.HKD","LU2746668974.SGD","LU1127390331.HKD","LU2491050071.SGD","IE00BJT1NW94.SGD","LLY","LU0786609619.USD","IE00BKDWB100.SGD","LU2237438978.USD","LU1093756168.USD","SGXZ81514606.USD","IE00BJLML261.HKD","BK4590","SG9999018857.SGD","LU0385154629.USD","LU1868836914.USD","SG9999015952.SGD","LU2211815571.USD","LU0203202063.USD","LU0109394709.USD","LU1868836757.USD","LU0353189763.USD","BK4144","SG9999001176.USD","GB00BDT5M118.USD","LU0417517546.SGD","LU1267930730.SGD","LU2324357040.USD","LU0114720955.EUR","LU2417539215.USD","LU2461242641.AUD","LU1720051108.HKD","LU0456855351.SGD","LU1623119135.USD","LU2236285917.USD","LU0432979614.USD","LU0320765992.SGD","IE00BWXC8680.SGD","LU0820561818.USD","IE00B2B36J28.USD","LU0823434583.USD","LU1868837300.USD","LU0323591593.USD","LU1551013342.USD","BK4533","LU0471298777.SGD","LU0640476718.USD","LU2357305700.SGD","SG9999017495.SGD","LU2168564495.EUR","LU2237443549.SGD","LU2361045086.USD","IE0005OL40V9.USD","LU0672654240.SGD","LU0466842654.USD","LU0820561909.HKD","IE00B1XK9C88.USD","LU0354030511.USD","IE00BFTCPJ56.SGD","LU1323610961.USD","LU0943347566.SGD","LU1983299246.USD","IE0004445015.USD","LU2360106947.USD","BK4581","LU0882574055.USD","LU2552382058.USD","LU1291159041.SGD","SG9999001176.SGD","SG9999013999.USD","IE00B7KXQ091.USD","LU0238689110.USD","LU0689472784.USD","SGXZ57979304.SGD","LU1035775433.USD","IE00BJJMRZ35.SGD","LU1069344957.HKD","LU0256863811.USD","LU0058720904.USD","LU2471134523.USD","BK4585","LU0198837287.USD","LU0122379950.USD","LU1280957306.USD","IE0004445239.USD","LU2552382132.HKD","LU2750360997.AUD","LU1551013425.SGD","IE00BK4W5L77.USD","LU0354030438.USD","LU0106261372.USD","LU2491050154.USD","SGXZ31699556.SGD","LU1868836591.USD","IE00BKPKM429.USD","LU1974910355.USD","LU2112291526.USD","LU0353189680.USD","SG9999014880.SGD","LU0316494557.USD","LU2462157665.USD","LU2471134796.USD","IE0002141913.USD","LU0234572021.USD","LU2237443978.SGD","SG9999015978.USD","LU2168564222.USD","BK4599","LU1917777945.USD","LU1868837136.USD","SG9999015986.USD","BK4516","IE00B4JS1V06.HKD","SG9999014906.USD","LU2168563687.JPY","LU0061475181.USD","LU2168564065.EUR","LU1814569148.SGD","LU0889565916.HKD","LU2237443895.HKD","BK4534","LU1720051017.SGD","IE00BJJMRX11.SGD","LU2491049909.HKD","LU0203201768.USD","LU0006306889.USD","IE00BFSS8Q28.SGD","LU1989771016.USD","IE00B775H168.HKD","LU1804176565.USD","SGXZ99366536.SGD","LU0094547139.USD","LU2602419157.SGD","LU0097036916.USD","LU0823434740.USD","IE00BFSS7M15.SGD","LU2750360641.GBP","IE00B4R5TH58.HKD","LU2237443622.USD","LU0266013472.USD","LU0109391861.USD"],"gpt_icon":1},{"id":"2590701483","title":"超20亿美元！辉瑞引进复星医药口服GLP-1药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2590701483","media":"佰傲谷BioValley","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590701483?lang=zh_cn&edition=fundamental","pubTime":"2025-12-10 12:11","pubTimestamp":1765339894,"startTime":"0","endTime":"0","summary":"实际上，辉瑞最早跟进减肥药开发的药企之一。辉瑞先是开了3款口服小分子GLP-1受体激动剂：Lotiglipron、Danuglipron和Danuglipron。但这三款管线相继失败了。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512101225569799e3dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"6692cc092fbadfcafce950a9c4d79e01","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512101225569799e3dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0234572021.USD","LU0868494617.USD","BK4144","LU0456855351.SGD","LU1894683264.USD","BK4533","NVO","LU0321505868.SGD","PFE","SG9999001176.USD","IE00BLSP4452.SGD","LU1023059063.AUD","SG9999002224.SGD","LU1093756325.SGD","SG9999013999.USD","BK4588","BK4568","LU1894683348.USD","LU1883839398.USD","IE0002270589.USD","IE00BBT3K403.USD","LU0225771236.USD","LU0321505439.SGD","BK4592","LU0289739699.SGD","BK4581","BK4599","LU1093756168.USD","SG9999011175.SGD","02196","BK4534","IE000M9KFDE8.USD","LU0058720904.USD","SG9999002232.USD","SG9999001176.SGD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU0985481810.HKD","BK4007","LU1066051498.USD","600196","IE00BLSP4239.USD","LU0225284248.USD","LU1066053197.SGD","IE00BZ1G4Q59.USD","BK4585","LU0306807586.USD","LU0122379950.USD","LU0306806265.USD","SG9999003800.SGD","BK4532","BK4550","IE00BKVL7J92.USD","LU0170899867.USD","IE00B19Z3581.USD","BK4590","SGXZ57979304.SGD","LU0154236417.USD"],"gpt_icon":1},{"id":"1117107485","title":"多尔切斯特矿业L.P.宣布威廉·凯西·麦克马宁从经理委员会退休；罗伯特·C·沃恩被任命为临时主席，阿尔伯特·G·南斯三世加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1117107485","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117107485?lang=zh_cn&edition=fundamental","pubTime":"2025-12-10 06:12","pubTimestamp":1765318331,"startTime":"0","endTime":"0","summary":"多尔切斯特矿业L.P.宣布威廉·凯西·麦克马宁从经理委员会退休；同时，罗伯特·C·沃恩被任命为临时主席，阿尔伯特·G·南斯三世加入董事会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","BK4213","DMLP"],"gpt_icon":0},{"id":"2590346711","title":"辉瑞(PFE)盘前升近1% 与药友制药签订GLP-1R独家许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2590346711","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590346711?lang=zh_cn&edition=fundamental","pubTime":"2025-12-09 20:59","pubTimestamp":1765285163,"startTime":"0","endTime":"0","summary":"金吾财讯 | 辉瑞(PFE)盘前股价小幅上扬，暂升0.81%，报25.98美元。复星医药控股子公司药友制药与辉瑞于2025年12月9日签订《许可协议》，药友制药就口服小分子胰高血糖素样肽-1受体（GLP-1R）激动剂（包括YP05002）及含有该活性成分的产品授予辉瑞于全球范围及领域（人类、动物所有适应症的治疗、诊断及预防）独家开发、使用、生产及商业化权利。药友制药将有权获得不可退还的首付款15,000万美元及至多35,000万美元的开发里程碑款项。另据报道公司与药明康德达成独家合作及许可协议。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/YjVhOWQ5NzA2M2E1Yzc2MTczNjIzNzY5MDQ1Ng==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YjVhOWQ5NzA2M2E1Yzc2MTczNjIzNzY5MDQ1Ng==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"295201","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU1023059063.AUD","BK4585","SG9999002224.SGD","LU1883839398.USD","BK4534","BK4533","SG9999001176.SGD","LU0868494617.USD","BK4568","IE00B19Z3581.USD","IE000M9KFDE8.USD","BK4588","LU0225771236.USD","LU1066051498.USD","SG9999013999.USD","PFE","BK4144","SG9999003800.SGD","BK1574","IE0002270589.USD","LU0306806265.USD","LU0289739699.SGD","BK4590","LU0122379950.USD","SGXZ57979304.SGD","IE00BLSP4452.SGD","IE00BLSP4239.USD","LU0234572021.USD","BK4550","LU0306807586.USD","IE00BBT3K403.USD","BK4599","LU0058720904.USD","LU0170899867.USD","LU0321505439.SGD","LU1066053197.SGD","SG9999002232.USD","SG9999001176.USD","LU0456855351.SGD","SG9999011175.SGD","LU1894683348.USD","BK4007","LU1057294990.SGD","LU0985481810.HKD","IE00B19Z3B42.SGD","BK4592","LU1894683264.USD","LU0225284248.USD","LU0321505868.SGD","BK4581"],"gpt_icon":0},{"id":"2589356327","title":"替尔泊肽进医保，中国GLP-1的竞争彻底变天！","url":"https://stock-news.laohu8.com/highlight/detail?id=2589356327","media":"健识局","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589356327?lang=zh_cn&edition=fundamental","pubTime":"2025-12-08 21:43","pubTimestamp":1765201393,"startTime":"0","endTime":"0","summary":"礼来是今年国家医保谈判的大赢家之一，主力产品替尔泊肽顺利纳入医保目录，适应症为2型糖尿病的治疗，成为继司美格鲁肽之后，第二个进入中国医保市场的进口GLP-1大热药物。今年11月初，德赫兰亲自带队参加替尔泊肽等产品的医保谈判，可见对中国市场重视程度和志在必得的态度。在替尔泊肽面前，国产GLP-1厂商不仅要比拼产品上市速度，更要面临一场商业化实力的严峻考验。截至目前，国内已获批的GLP-1RA原研药物共9款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208214925a72b4afa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208214925a72b4afa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0154236417.USD","BK4590","BK4585","LU1093756325.SGD","IE00BZ1G4Q59.USD","BK4532","IE00BKVL7J92.USD","NVO","03692","03933","BK4588","BK4599","01801","BK4144","01276","LLY","LU1093756168.USD"],"gpt_icon":1},{"id":"2589333626","title":"安徽省安庆市市场监督管理局公示2025年旅游产品质量联动抽查结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2589333626","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589333626?lang=zh_cn&edition=fundamental","pubTime":"2025-12-08 16:34","pubTimestamp":1765182840,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 据安徽省安庆市市场监督管理局网站消息，日前，安庆市市场监管局会同宣城市市场监管局、池州市市场监管局、黄山市市场监管局开展2025年旅游产品质量联动监督抽查。此次安庆市市场监管局共抽查汽车用化学品、旅游用品、纤维制品、儿童玩具等旅游产品25批次。具体抽查结果详见下表。2025年安庆市旅游产品质量联动监督抽查结果序号抽查领域抽查产品商标规格型号生产日期/批号被抽样单位名称标称生产单位名称是否符合","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-12-08/doc-inhaarpa3576770.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4598","AB","LU0029874061.USD","LU0128526141.USD","BK4135","BK4590"],"gpt_icon":0},{"id":"2589537816","title":"“五虎争霸赛”圆满收官｜JST、SUN、NFT 夺魁，SUN.io 接棒生态新动能","url":"https://stock-news.laohu8.com/highlight/detail?id=2589537816","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589537816?lang=zh_cn&edition=fundamental","pubTime":"2025-12-05 23:34","pubTimestamp":1764948869,"startTime":"0","endTime":"0","summary":" JST、SUN、NFT 三大资产领跑，引爆交易与社区活跃度，更推动大量资金涌入生态，最终由一站式平台 SUN.io 承接并转化为长期增长动能。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2226742","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4138","BK4590","SUN"],"gpt_icon":0},{"id":"2589896048","title":"石药集团(01093)：GLP-1/GIP受体双偏向性激动多肽注射液在美国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2589896048","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589896048?lang=zh_cn&edition=fundamental","pubTime":"2025-12-05 18:55","pubTimestamp":1764932156,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的GLP-1/GIP受体双偏向性激动多肽注射液(该产品)已获得美国食品药品监督管理局批准，可在美国开展临床试验。该产品有望成为中国首款进入临床阶段的GLP-1/GIP受体双偏向激动剂，可选择性激活cAMP通路，显着降低β-arrestin募集，从而减少受体内吞及脱敏，提高药效和效果持续性。非人灵长类重复给药毒理研究显示，该产品耐受性良好，未观察到任何呕吐及胃肠道不良反应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378277.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0008369823.USD","BK1191","LU1807302812.USD","IE00B5MMRT66.SGD","LU0140636845.USD","01093","LU0072913022.USD","IE00BZ08YT58.USD","LU1951186391.HKD","LU1008478684.HKD","LU0315179316.USD","LU1226287875.USD","SG9999004220.SGD","LU1328277881.USD","BK4144","GLP","LU1993786604.SGD","IE00B031HY20.USD","LU0314109678.HKD","IE00B543WZ88.USD","BK4590","LU0067412154.USD","LU2039709279.SGD","BK1521","HK0000165453.HKD","LU1152091754.HKD","IE00BZ08YR35.GBP","LU1960683339.HKD","LU1226287792.SGD","LU0880133367.SGD","LU1226288253.USD","BK1515","IE00BZ08YS42.EUR","IE0008368742.USD","LU0501845795.SGD","LU1226288170.HKD","LU1813983027.USD","LU0326950275.SGD","LU1226287529.USD","LU1152091168.USD"],"gpt_icon":0},{"id":"2589217867","title":"AETDEW 携手 AB 慈善基金会 X AB DAO 共解发展中国家能源难题","url":"https://stock-news.laohu8.com/highlight/detail?id=2589217867","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589217867?lang=zh_cn&edition=fundamental","pubTime":"2025-12-05 16:17","pubTimestamp":1764922667,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，AETDEW（发展中国家世界工程与技术研究院）于吉隆坡总部与AB慈善基金会X AB DAO正式签署合作备忘录，合力破解发展中国家能源发展困境。\n\n本次签约有多位行业权威见证，包括 AETDEW 执行董事 Dr. Ir. Ts. Wong Chee Fui、AB慈善基金会高级顾问 Dr Moneef R. Zou’bi 等，为合作筑牢专业协作根基。\n\n根据约定，双方将在工程技术升级、智慧电网搭建、可再生能源落地等领域深度联动，结合先进技术与公益资源对接需求。AB 慈善基金会依托 AB DAO 的技术与资金，还将以区块链、AI 技术打造透明能源公益体系，为相关地区能源事业赋能。 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2226588","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","LU0128526141.USD","LU0029874061.USD","BK4590","159945","BK4598","AB"],"gpt_icon":0},{"id":"2588882203","title":"综述 2-受资本市场提振，加拿大道明银行、墨尔本银行和加拿大帝国商业银行利润超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2588882203","media":"路透中文","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588882203?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 21:37","pubTimestamp":1764855461,"startTime":"0","endTime":"0","summary":"综述 2-受资本市场提振，加拿大道明银行、墨尔本银行和加拿大帝国商业银行利润超预期添加各银行电话会议的评论、股票、PIX加拿大银行总结第四季度财报 首席执行官称经济仍有韧性高管们表示，资本市场的发展势头将持续下去 Nivedita Balu. 今年到目前为止，道明银行的股价飙升了 53.8%，墨尔本银行上涨了 27%，加拿大帝国商业银行上涨了 34%，加拿大皇家银行、丰业银行和国民银行的平均涨幅约为 27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nL4S3XA0ZJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FUN","BK4216","BK4590"],"gpt_icon":0},{"id":"2588988906","title":"司美格鲁肽等GLP-1药物写入WHO全球指南用于肥胖症治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2588988906","media":"21财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588988906?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 20:01","pubTimestamp":1764849707,"startTime":"0","endTime":"0","summary":"为应对全球日益严峻的肥胖健康挑战，近日，世界卫生组织发布了首个关于将胰高血糖素样肽-1类药物用于治疗肥胖的全球指南。2025年9月，世卫组织已将GLP-1类药物纳入《基本药物目录》，用于高风险人群的2型糖尿病管理。此次新指南对GLP-1药物用于肥胖治疗提出了有条件的推荐，强调应将其作为包括健康饮食、规律运动和专业医务工作者健康指导在内的综合管理方案的一部分。新指南有助于降低因肥胖及其并发症带来的医疗成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204200204a723bda3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204200204a723bda3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","BK4144","BK4007","LU0154236417.USD","NVO","BK4590","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4599","BK4532","BK4585","BK4588","GLP","LU1093756325.SGD"],"gpt_icon":1},{"id":"2588007417","title":"中国生物制药(01177)：TQF3250“口服偏向型GLP-1受体激动剂”临床试验申请获NMPA、FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2588007417","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588007417?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 17:27","pubTimestamp":1764840424,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，集团自主研发的创新药TQF3250胶囊“口服偏向型GLP-1受体激动剂”的临床试验申请已获得中国国家药品监督管理局和美国食品药品监督管理局的批准，拟用于减重。TQF3250是一款口服小分子偏向型GLP-1受体激动剂。与传统GLP-1药物相比，TQF3250通过选择性激活cAMP偏向的GLP-1受体信号通路，促进胰岛素分泌，同时减少β-arrestin募集和受体内吞，从而延长药效持续时间。除减重适应症外，TQF3250用于治疗2型糖尿病的临床试验申请已获NMPA批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4144","HK0000165453.HKD","BK1521","BK1589","BK4590","BK1191","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","BK1515","GLP","IE00BZ08YT58.USD","01177"],"gpt_icon":0},{"id":"1134053663","title":"Plains All American Pipeline - 公司于12月1日终止Epic信贷协议并偿还未偿还金额 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1134053663","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134053663?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 05:20","pubTimestamp":1764796816,"startTime":"0","endTime":"0","summary":"Plains All American Pipeline - 公司于12月1日终止Epic信贷协议并偿还未偿还金额 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","BK4590","PAA"],"gpt_icon":0},{"id":"1160145101","title":"汉堡王准备迎接GLP-1的变化","url":"https://stock-news.laohu8.com/highlight/detail?id=1160145101","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160145101?lang=zh_cn&edition=fundamental","pubTime":"2025-12-03 22:17","pubTimestamp":1764771426,"startTime":"0","endTime":"0","summary":"餐饮行业高管正在关注美国人使用GLP-1减肥药物后销售放缓的迹象，但汉堡王的母公司餐饮品牌国际（Restaurant Brands International）表示，他们已经做好了应对需求变化的准备。首席执行官Josh Kobza在一次投资者活动中表示，减肥药用户在使用这些药物时通常会寻求高蛋白食品，而汉堡王的产品富含蛋白质。Kobza表示，该连锁店的双层奶酪汉堡尺寸较小，肉与面包的比例高，非常适合GLP-1用户的需求。\n","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","BK4209","BK4144","GLP","QSR"],"gpt_icon":0},{"id":"2588019385","title":"不止于交易：孙悟空如何用“真金白银”为SUN铸造价值闭环","url":"https://stock-news.laohu8.com/highlight/detail?id=2588019385","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588019385?lang=zh_cn&edition=fundamental","pubTime":"2025-12-03 16:35","pubTimestamp":1764750950,"startTime":"0","endTime":"0","summary":"  ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2225901","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4138","SImain","BK4590","SUN","QImain"],"gpt_icon":0},{"id":"2588101091","title":"AB 慈善基金会再次追加 500 万，三次捐款共 1500 万港币，与中国和平统一促进会香港总会践行“狮子山下精神”","url":"https://stock-news.laohu8.com/highlight/detail?id=2588101091","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588101091?lang=zh_cn&edition=fundamental","pubTime":"2025-12-03 11:40","pubTimestamp":1764733230,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，2025 年 11 月 26  日下午，香港新界大埔宏福苑突发五级大火，造成重大人员伤亡与财产损失。这场严重灾难牵动全港乃至全球华人社会的心，各界紧急行动，通过捐款、物资与志愿服务支援受灾居民。\n\n在此背景下，2025 年 11 月 28 日，AB 慈善基金会捐款 1000 万港币，12 月 1 日追加 200 万港币，两次通过中国和平统一促进会香港总会捐款共 1200 万港币。\n\n12 月 2 日，AB慈善基金会再度追加捐款 300 万港币。至此，AB 慈善基金会就本次大埔宏福苑火灾相关项目，已通过中国和平统一促进会香港总会累计捐出资金共计 1500 万港币，希望在香港特区政府及社会各界的共同努力下，帮助受灾居民尽快恢复正常生活，延续“狮子山下精神”所代表的守望相助与团结互助。\n\nAB 慈善基金会表示，后续将根据实际情况继续捐款。\n\nAB 慈善基金会是一家在爱尔兰注册成立并享有欧盟法人地位的独立国际非政府组织，其技术与资金支持来源于 AB DAO。基金会致力于利用区块链、人工智能等前沿技术，构建一个透明、可信、可追溯的公益基础设施，从而促进教育、医疗、环境及人道主义援助等公共事业的可持续发展。 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2225821","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4598","AB","BK4590","LU0128526141.USD","LU0029874061.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":36,"code":"91000000","status":"200"}]}}